BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 8196827)

  • 1. [Clinical study on the recurrence of meningiomas: correlating factors for the recurrence and therapeutic prognosis of meningiomas].
    Miyagami M; Miyagi A; Kido G; Tsubokawa T
    No Shinkei Geka; 1994 May; 22(5):421-8. PubMed ID: 8196827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
    Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
    Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convexity meningiomas: study of recurrence factors with special emphasis on the cleavage plane in a series of 100 consecutive patients.
    Alvernia JE; Dang ND; Sindou MP
    J Neurosurg; 2011 Sep; 115(3):491-8. PubMed ID: 21663413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
    Roser F; Samii M; Ostertag H; Bellinzona M
    Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
    Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
    Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term surgical outcomes of spinal meningiomas.
    Nakamura M; Tsuji O; Fujiyoshi K; Hosogane N; Watanabe K; Tsuji T; Ishii K; Toyama Y; Chiba K; Matsumoto M
    Spine (Phila Pa 1976); 2012 May; 37(10):E617-23. PubMed ID: 22146282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of meningioma. Clinico-epidemiologic and histologic studies].
    Guski M; Martin H
    Zentralbl Neurochir; 1984; 45(3):219-32. PubMed ID: 6506933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of malignant meningiomas].
    Kojima T; Waga S; Itoh H; Matsubara T; Kuga Y
    No Shinkei Geka; 1990 Oct; 18(10):939-46. PubMed ID: 2234295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
    Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
    Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spheno-orbital meningiomas: surgical approaches and outcome according to the intraorbital tumor extent.
    Mariniello G; Maiuri F; Strianese D; Donzelli R; Iuliano A; Tranfa F; de Divitiis E; Bonavolontà G
    Zentralbl Neurochir; 2008 Nov; 69(4):175-81. PubMed ID: 18666054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery for convexity meningiomas.
    Morokoff AP; Zauberman J; Black PM
    Neurosurgery; 2008 Sep; 63(3):427-33; discussion 433-4. PubMed ID: 18812953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of recurrences of meningiomas following neurosurgical resection].
    Kajiwara K; Fudaba H; Tsuha M; Ueda H; Mitani T; Nishizaki T; Aoki H
    No Shinkei Geka; 1989 Dec; 17(12):1125-31. PubMed ID: 2615895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood and adolescent meningiomas: a report of 38 cases and review of literature.
    Menon G; Nair S; Sudhir J; Rao BR; Mathew A; Bahuleyan B
    Acta Neurochir (Wien); 2009 Mar; 151(3):239-44; discussion 244. PubMed ID: 19238320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical management of jugular foramen meningiomas: a series of 13 cases and review of the literature.
    Sanna M; Bacciu A; Falcioni M; Taibah A; Piazza P
    Laryngoscope; 2007 Oct; 117(10):1710-9. PubMed ID: 17690614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasagittal meningiomas: follow-up review.
    Colli BO; Carlotti CG; Assirati JA; Dos Santos MB; Neder L; Dos Santos AC
    Surg Neurol; 2006; 66 Suppl 3():S20-7; discussion S27-8. PubMed ID: 17081848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of recurrent convexity meningioma with malignant transformation 26 years after total tumor removal].
    Ohta M; Takeshita I
    No Shinkei Geka; 2001 Jan; 29(1):81-5. PubMed ID: 11218772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
    Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
    Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of tuberculum sellae meningiomas:a long-term follow-up study.
    Ohta K; Yasuo K; Morikawa M; Nagashima T; Tamaki N
    J Clin Neurosci; 2001 May; 8 Suppl 1():26-31. PubMed ID: 11386822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between malignant subtypes of meningioma and clinical outcome.
    Ko KW; Nam DH; Kong DS; Lee JI; Park K; Kim JH
    J Clin Neurosci; 2007 Aug; 14(8):747-53. PubMed ID: 17499508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.